[Blocking PlGF, a future in anti-angiogenic therapy?].
Galaup
Ariane
A
Germain
Stéphane
S
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000906:Antibodies / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000503:physiopathology; D008565:Membrane Proteins; D045726:Metalloproteases / Q000037:antagonists & inhibitors; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy; D011506:Proteins / Q000276:immunology* / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000906:Antibodies; D004791:Enzyme Inhibitors; D008565:Membrane Proteins; C098069:PIGF protein, human; D011506:Proteins; D045726:Metalloproteases